Medical Science Liaison - Great Lakes

Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.

In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets, the company has three investigational clinical-stage programs currently enrolling: vepdegestrant for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-102 for the treatment of patients with neurodegenerative disorders, and ARV-393 for the treatment of patients with relapsed/refractory non-Hodgkin Lymphoma and potentially other lymphomas.

In April 2024, Arvinas entered into a transaction with Novartis, including a global license agreement for the development and commercialization of the clinical stage PROTAC® androgen receptor protein degrader ARV-766 for the treatment of prostate cancer. The transaction closed in May 2024.

#TeamArvinas is made up of approximately 450 passionate and curious employees, whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue innovation, think creatively, and give back. They are driven by the company’s values and mission – to improve the lives of patients with serious diseases by pioneering therapies created with our revolutionary PROTAC® protein degradation platform. We’re really excited about the work we’re doing inside and outside of Arvinas, and think you will be, too. But don’t just take our word for it – learn more about life at Arvinas and what employees have to say.

For more information, please visit www.arvinas.com. 

 

Position Summary

The Medical Science Liaison (MSL) is a field-based scientific and clinical expert. The MSL will be responsible for developing credible peer-to-peer relationships with scientific experts and other healthcare providers, engaging in scientific exchange of data and other medical and/or scientific information, and supporting Arvinas’ research initiatives.  This MSL will cover the Great Lakes Region: Michigan, Ohio, Kentucky, Indiana, and southern Illinois.

This position reports to the Senior Director Regional Team Lead, Field Medical Affairs, and will be based remotely from a location within the U.S.

Principal Responsibilities

Key responsibilities of this role include, but are not limited to:

• Establish and maintain credible peer-to-peer scientific relationships with national, regional, and local opinion leaders in addition to other health care providers.
• Develop strategic engagement plans in support of the overall medical affairs plan.
• Deliver scientifically accurate, balanced, and unbiased medical and scientific presentations to stakeholders, healthcare providers, and patient groups.
• Attend scientific conferences to collect and report relevant scientific and clinical data.
• Assist with Arvinas-sponsored clinical trials and drug development activities.
• Compliantly facilitate the submission and review of investigator-sponsored research proposals
• Serve as a resource of clinical and scientific information for internal cross-functional partners.
• Capture, analyze, and share insights from various external engagement activities (e.g., scientific expert, investigator, HCP, and payer interactions)
• Respond to unsolicited requests for medical information.
• Provide input into medical strategy for pipeline compounds.
• Ensure and maintain compliance with all company policies, laws, industry, and regul